Aster Dm Quality Care Ltd vs Yatharth Hospital Trauma Care Services Ltd Stock Comparison
Aster Dm Quality Care Ltd vs Yatharth Hospital Trauma Care Services Ltd Stock Comparison
Last Updated on: Oct 28, 2026
Key Highlights
The Latest Trading Price of Aster DM Quality Care Ltd is ₹ 669.65 as of 28 Oct 15:30
. The P/E Ratio of Aster DM Quality Care Ltd changed from 46.2 on March 2021 to 89.7 on March 2026 . This represents a CAGR of 11.69% over 6 yearsThe P/E Ratio of Yatharth Hospital & Trauma Care Services Ltd changed from 31.3 on March 2024 to 33.9 on March 2026 . This represents a CAGR of 2.70% over 3 years The Market Cap of Aster DM Quality Care Ltd changed from ₹ 6858 crore on March 2021 to ₹ 34794 crore on March 2026 . This represents a CAGR of 31.08% over 6 yearsThe Market Cap of Yatharth Hospital & Trauma Care Services Ltd changed from ₹ 3582 crore on March 2024 to ₹ 5946 crore on March 2026 . This represents a CAGR of 18.40% over 3 years The revenue of Aster DM Quality Care Ltd for the Jun '26 is ₹ 1347 crore as compare to the Mar '26 revenue of ₹ 1218 crore. This represent the growth of 10.57% The revenue of Yatharth Hospital & Trauma Care Services Ltd for the Jun '26 is ₹ 397.01 crore as compare to the Mar '26 revenue of ₹ 348.67 crore. This represent the growth of 13.86% The ebitda of Aster DM Quality Care Ltd for the Jun '26 is ₹ 178.58 crore as compare to the Mar '26 ebitda of ₹ 260.58 crore. This represent the decline of -31.47% The ebitda of Yatharth Hospital & Trauma Care Services Ltd for the Jun '26 is ₹ 96.04 crore as compare to the Mar '26 ebitda of ₹ 87.02 crore. This represent the growth of 10.37% The net profit of Aster DM Quality Care Ltd changed from ₹ 5152 crore to ₹ 29.28 crore over 9 quarters. This represents a CAGR of -89.95%
The net profit of Yatharth Hospital & Trauma Care Services Ltd changed from ₹ 30.38 crore to ₹ 45.42 crore over 9 quarters. This represents a CAGR of 19.57%
The Dividend Payout of Aster DM Quality Care Ltd changed from 3818 % on March 2024 to 58.04 % on March 2026 . This represents a CAGR of -75.23% over 3 yearsThe Dividend Payout of Yatharth Hospital & Trauma Care Services Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .
About Aster DM Healthcare Ltd
Aster DM Healthcare Limited was erstwhile established as 'Aster DM Healthcare Private Limited', a private limited company on 18 January, 2008.
On November 29, 2013.
The Company was converted into a public limited company and the name of the Company was changed to Aster DM Healthcare Limited.
Aster DM Healthcare Limited is one of the leading healthcare player in the GCC and India.
Founded in 1987 by Dr. Azad Moopen, the Company has emerged as an integrated healthcare service organization that provides the complete circle of care to people through network of hospitals, clinics, labs and pharmacies, providing primary, secondary, tertiary to quaternary care to all segments of the population.
Aster DM offer a diverse portfolio of specialised brands that serve patients in Primary, Secondary, Tertiary, and Quaternary Care, Healthcare Retailing, Diagnostic Laboratories, Digital Health, and Medical Education.
About Yatharth Hospital & Trauma Care Services Ltd
Yatharth Hospital & Trauma Care Services Limited was formerly incorporated as a Private Limited Company in Delhi dated February 28, 2008.
On November 3, 2021, the status converted into a Public Company and name of the Company was changed to Yatharth Hospital & Trauma Care Services Limited' on November 18, 2021 issued by the RoC.
Yatharth Hospitals and Trauma Care Services Limited is a network of super speciality hospitals across Delhi National Capital Region (NCR) and Madhya Pradesh, capitalising on the robust healthcare infrastructure in these regions to serve a wide patient base in need of tertiary care.
The Company operate three super specialty hospitals in Delhi NCR, i.e., at Greater Noida, Uttar Pradesh.
The super speciality tertiary care
hospital currently operates with 400 beds, including 112 critical care beds and 9 modular operation theatres, among other surgical facilities.
FAQs for the comparison of Aster DM Quality Care Ltd and Yatharth Hospital & Trauma Care Services Ltd
Which company has a larger market capitalization, Aster DM Healthcare Ltd or Yatharth Hospital & Trauma Care Services Ltd?
Market cap of Aster DM Healthcare Ltd is 58,371 Cr while Market cap of Yatharth Hospital & Trauma Care Services Ltd is 9,119 Cr
What are the key factors driving the stock performance of Aster DM Healthcare Ltd and Yatharth Hospital & Trauma Care Services Ltd?
The stock performance of Aster DM Healthcare Ltd and Yatharth Hospital & Trauma Care Services Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Aster DM Healthcare Ltd and Yatharth Hospital & Trauma Care Services Ltd?
As of October 28, 2026, the Aster DM Healthcare Ltd stock price is INR ₹669.65. On the other hand, Yatharth Hospital & Trauma Care Services Ltd stock price is INR ₹946.5.
How do dividend payouts of Aster DM Healthcare Ltd and Yatharth Hospital & Trauma Care Services Ltd compare?
To compare the dividend payouts of Aster DM Healthcare Ltd and Yatharth Hospital & Trauma Care Services Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.